Treatment and outcome patterns of patients with Waldenström's macroglobulinemia: a large, multicenter retrospective review in China.

Leukemia & Lymphoma
Xin-Xin CaoLu-Gui Qiu

Abstract

In this study, we aimed to investigate treatment options and the prognosis of patients with WM in China. This retrospective study included 1141 patients diagnosed with symptomatic WM between January 2003 and December 2019 at 35 tertiary hospitals in 22 provinces of China. Fifty-four patients (7.3%) received monotherapy, 264 (36.0%) received chemoimmunotherapy, 395 (53.8%) received other combination regimens without rituximab, and 21 (2.9%) received ibrutinib. Using a multivariable Cox regression model, age > 65 years old, platelets <100 × 109/L, serum albumin <3.5 g/dl, β2 microglobulin concentration ≥4 mg/L and LDH ≥250 IU/L predicted poor OS. In summary, our study showed that frontline treatment choices for WM are widely heterogeneous. We validated most of the established prognostic factors in the rIPSS (age >65 years, LDH ≥250 IU/L, ALB <3.5 g/dl and β2 microglobulin ≥4 mg/L) together with PLT ≤ 100 × 109/L indicate a poor prognosis for patients with WM.

References

Feb 7, 2009·Blood·Pierre MorelGiampaolo Merlini
Dec 13, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Véronique LeblondRoger G Owen
Jun 21, 2013·International Journal of Cancer. Journal International Du Cancer·Masako IwanagaTomotaka Sobue
Mar 31, 2015·Blood Cancer Journal·A Oza, S V Rajkumar
May 24, 2015·Blood·Steven P Treon
Jun 2, 2018·The New England Journal of Medicine·Meletios A DimopoulosUNKNOWN iNNOVATE Study Group and the European Consortium for Waldenström’s Macroglobulinemia
Jul 1, 2018·The Lancet. Haematology·Christian BuskeUNKNOWN European Consortium for Waldenström's Macroglobulinemia
May 24, 2019·Leukemia·Efstathios KastritisMeletios A Dimopoulos
Sep 16, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Steven P TreonJorge J Castillo

❮ Previous
Next ❯

Related Concepts

Related Feeds

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Related Papers

Annals of Oncology : Official Journal of the European Society for Medical Oncology
Meletios Athanasios DimopoulosIrene M Ghobrial
La Revue de médecine interne
Stephanie PoulainXavier Leleu
© 2021 Meta ULC. All rights reserved